The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses

References

• TopalianSLDrakeCGPardollDMImmune checkpoint blockade: a common denominator approach to cancer therapyCancer Cell201527445046125858804
   PubMed Web of Science ®Google Scholar
• GreenmanCStephensPSmithRPatterns of somatic mutation in human cancer genomesNature2007446713215315817344846
   PubMed Web of Science ®Google Scholar
• NavinNKendallJTrogeJTumour evolution inferred by single-cell sequencingNature20114727341909421399628
   PubMed Web of Science ®Google Scholar
• ReardonDAWenPYGlioma in 2014: unravelling tumour heterogeneity-implications for therapyNat Rev Clin Oncol2015122697025560529
   PubMed Web of Science ®Google Scholar
• RussellSJPengKWBellJCOncolytic virotherapyNat Biotechnol201230765867022781695
   PubMed Web of Science ®Google Scholar
• Le BoeufFBatenchukCVähä-KoskelaMModel-based rational design of an oncolytic virus with improved therapeutic potentialNat Commun20134197423764612
   PubMed Web of Science ®Google Scholar
• Le BoeufFBellJCUnited virus: the oncolytic tag-team against cancer!Cytokine Growth Factor Rev2010212–320521120227326
   PubMed Web of Science ®Google Scholar
• Le BoeufFDialloJSMcCartJASynergistic interaction between oncolytic viruses augments tumor killingMol Ther201018588889520234341
   PubMed Web of Science ®Google Scholar
• YangSGuoZSO’MalleyMEYinXZehHJBartlettDLA new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virusGene Ther200714863864717268533
   PubMed Web of Science ®Google Scholar
• StojdlDFLichtyBKnowlesSExploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virusNat Med20006782182510888934
   PubMed Web of Science ®Google Scholar
• MassagueJTGFbeta in cancerCell2008134221523018662538
   PubMed Web of Science ®Google Scholar
• KleinovinkJWvan HallTOssendorpFFransenMFPD-L1 immune suppression in cancer: tumor cells or host cells?Oncoimmunology201767e132598228811961
   PubMed Web of Science ®Google Scholar
• KaufmanHLKohlhappFJZlozaAOncolytic viruses: a new class of immunotherapy drugsNat Rev Drug Discov201514964266226323545
   PubMed Web of Science ®Google Scholar
• ParatoKABreitbachCJLe BoeufFThe oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancersMol Ther201220474975822186794
   PubMed Web of Science ®Google Scholar
• BreitbachCJBurkeJJonkerDIntravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humansNature201147773629910221886163
   PubMed Web of Science ®Google Scholar
• Downs-CannerSGuoZSRavindranathanRPhase 1 study of intravenous oncolytic poxvirus (vvDD) in patients with advanced solid cancersMol Ther20162481492150127203445
   PubMed Web of Science ®Google Scholar
• JohnsonDBPuzanovIKelleyMCTalimogene laherparepvec (T-VEC) for the treatment of advanced melanomaImmunotherapy20157661161926098919
   PubMed Web of Science ®Google Scholar
• PuzanovIMilhemMMMinorDTalimogene laherparepvec in combination with ipilimumab in previously untreated, unresectable stage IIIB-IV melanomaJ Clin Oncol201634222619262627298410
   PubMed Web of Science ®Google Scholar
• ZamarinDHolmgaardRBSubudhiSKLocalized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapySci Transl Med20146226226ra32
   PubMed Web of Science ®Google Scholar
• SamsonAScottKJTaggartDIntravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockadeSci Transl Med201810422eaam757729298869
   PubMed Web of Science ®Google Scholar
• LichtyBDBreitbachCJStojdlDFBellJCGoing viral with cancer immunotherapyNat Rev Cancer201414855956724990523
   PubMed Web of Science ®Google Scholar
• BhatiaSFrangioniJVHoffmanRMIafrateAJPolyakKThe challenges posed by cancer heterogeneityNat Biotechnol201230760461022781679
   PubMed Web of Science ®Google Scholar
• FedeleCTothillRWMcArthurGANavigating the challenge of tumor heterogeneity in cancer therapyCancer Discov20144214614824501303
   PubMed Web of Science ®Google Scholar
• GarciaVKrishnanRDavisCHigh-throughput titration of luciferase-expressing recombinant virusesJ Vis Exp2014915189025285536
   PubMed Web of Science ®Google Scholar
• Rodriguez-BrenesIAHofacreAFanHWodarzDComplex dynamics of virus spread from low infection multiplicities: implications for the spread of oncolytic virusesPLoS Comput Biol2017131e100524128107341
   PubMed Web of Science ®Google Scholar
• FassLImaging and cancer: a reviewMol Oncol20082211515219383333
   PubMed Web of Science ®Google Scholar
• DayCPMerlinoGVan DykeTPreclinical mouse cancer models: a maze of opportunities and challengesCell20151631395326406370
   PubMed Web of Science ®Google Scholar
• LeeWCChangC-HHoC-LEarly detection of tumor response by FLT/microPET Imaging in a C26 murine colon carcinoma solid tumor animal modelJ Biomed Biotechnol2011201153590221869861
   PubMedGoogle Scholar
• MenezesGLKnuttelFMStehouwerBLPijnappelRMvan den BoschMA1Magnetic resonance imaging in breast cancer: a literature review and future perspectivesWorld J Clin Oncol201452617024829852
   PubMedGoogle Scholar
• PowerATWangJFallsTJCarrier cell-based delivery of an oncolytic virus circumvents antiviral immunityMol Ther200715112313017164783
   PubMed Web of Science ®Google Scholar
• de JongMEssersJvan WeerdenWMImaging preclinical tumour models: improving translational powerNat Rev Cancer201414748149324943811
   PubMed Web of Science ®Google Scholar
• ShinDVigneswaranNGillenwaterARichards-KortumRAdvances in fluorescence imaging techniques to detect oral cancer and its precursorsFuture Oncol2010671143115420624126
   PubMed Web of Science ®Google Scholar
• YuEYBishopMZhengBMagnetic particle imaging: a novel in vivo imaging platform for cancer detectionNano Lett20171731648165428206771
   PubMed Web of Science ®Google Scholar
• MansuetiJRMaillieSA review of non-small cell lung cancer post-treatment follow-up imaging procedures with PET/CT scans versus CT scans and the effect on patient survivalInt J Radiat Oncol Biol Phys2017981231
   Web of Science ®Google Scholar
• MarianiGBruselliLKuwertTA review on the clinical uses of SPECT/CTEur J Nucl Med Mol Imaging201037101959198520182712
   PubMed Web of Science ®Google Scholar
• FarwellMDPrymaDAMankoffDAPET/CT imaging in cancer: current applications and future directionsCancer2014120223433344524947987
   PubMed Web of Science ®Google Scholar
• DaiGLevyOCarrascoNCloning and characterization of the thyroid iodide transporterNature199637965644584608559252
   PubMed Web of Science ®Google Scholar
• PinkeLADeanDSBergertERSpitzwegCDuttonCMMorrisJCCloning of the mouse sodium iodide symporterThyroid2001111093593911716040
   PubMed Web of Science ®Google Scholar
• SmanikPALiuQFurmingerTLCloning of the human sodium lodide symporterBiochem Biophys Res Commun199622623393458806637
   PubMed Web of Science ®Google Scholar
• WangJArulanandamRWassenaarREnhancing expression of functional human sodium iodide symporter and somatostatin receptor in recombinant oncolytic vaccinia virus for in vivo imaging of tumorsJ Nucl Med201758222122727635026
   PubMed Web of Science ®Google Scholar
• HoffmanRMApplication of GFP imaging in cancerLab Invest201595443245225686095
   PubMed Web of Science ®Google Scholar
• RuotsalainenJJKaikkonenMUNiittykoskiMClonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma modelGene Ther2015221657525231172
   PubMed Web of Science ®Google Scholar
• Vaha-KoskelaMJLe BoeufFLemayCResistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental gliomaJ Virol20138742363236623221568
   PubMed Web of Science ®Google Scholar
• SoboleskiMROaksJHalfordWPGreen fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cellsFASEB J200519344044215640280
   PubMed Web of Science ®Google Scholar
• YuYAShabahangSTimiryasovaTMVisualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteinsNat Biotechnol200422331332014990953
   PubMed Web of Science ®Google Scholar
• AlbertiCFrom molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapyEur Rev Med Pharmacol Sci201216141925193323242718
   PubMed Web of Science ®Google Scholar
• DengHTangNStiefAEOncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virusLeukemia200822122261226418509356
   PubMed Web of Science ®Google Scholar
• ZhangQYuYAWangEEradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virusCancer Res20076720100381004617942938
   PubMed Web of Science ®Google Scholar
• ParviainenSAhonenMDiaconuICD40 ligand and tdTomatoarmed vaccinia virus for induction of antitumor immune response and tumor imagingGene Ther201421219520424305418
   PubMed Web of Science ®Google Scholar
• BinzEBerchtoldSBeilJChemovirotherapy of pancreatic adenocarcinoma by combining oncolytic vaccinia virus GLV-1h68 with nab-paclitaxel plus gemcitabineMol Ther Oncolytics20176102128607950
   PubMed Web of Science ®Google Scholar
• CostantiniLMSnappELGoing viral with fluorescent proteinsJ Virol201589199706970826202231
   PubMed Web of Science ®Google Scholar
• BarryMAMaySWeaverEAImaging luciferase-expressing virusesMethods Mol Biol2012797798721948470
   PubMedGoogle Scholar
• BrunJMahoneyDJLe BoeufFOncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosumInt J Cancer2013132372673122733395
   PubMed Web of Science ®Google Scholar
• ColemanSMMcGregorAA bright future for bioluminescent imaging in viral researchFuture Virol201510216918326413138
   PubMed Web of Science ®Google Scholar
• ZhangFPerez-MartinEJuleffNCharlestonBSeagoJA replication-competent foot-and-mouth disease virus expressing a luciferase reporterJ Virol Methods2017247384428532601
   PubMed Web of Science ®Google Scholar
• StritzkerJKirscherLScadengetMVaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancerProc Natl Acad Sci USA201311093316332023401518
   PubMed Web of Science ®Google Scholar
• KaurBChioccaEACripeTPOncolytic HSV-1 virotherapy: clinical experience and opportunities for progressCurr Pharm Biotechnol20121391842185121740359
   PubMed Web of Science ®Google Scholar
• Munoz-AlvarezKAAltomonteJLaitinenIPET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat modelMol Ther2015234728743625609160
   PubMed Web of Science ®Google Scholar
• Abate-DagaDAndreuNCamacho-SánchezJOncolytic adenoviruses armed with thymidine kinase can be traced by PET imaging and show potent antitumoural effects by ganciclovir dosingPLoS One2011610e2614222028820
   PubMed Web of Science ®Google Scholar
• SlooterGDMearadjiABreemanWASomatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumoursBr J Surg2001881314011136306
   PubMed Web of Science ®Google Scholar
• RogersBEMcLeanSFKirkmanRLIn vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vectorClin Cancer Res19995238339310037188
   PubMed Web of Science ®Google Scholar
• ZinnKRBuchsbaumDJChaudhuriTRMountzJMGrizzleWERogersBENoninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188ReJ Nucl Med200041588789510809205
   PubMed Web of Science ®Google Scholar
• McCartJAMehtaNScollardDOncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotideMol Ther200410355356115336655
   PubMed Web of Science ®Google Scholar
• MorozMASerganovaIZanzonicoPImaging hNET reporter gene expression with 124I-MIBGJ Nucl Med200748582783617475971
   PubMed Web of Science ®Google Scholar
• BraderPKellyKJChenNImaging a genetically engineered oncolytic vaccinia virus (GLV-1h99) using a human norepinephrine transporter reporter geneClin Cancer Res20091511379180119470726
   PubMed Web of Science ®Google Scholar
• BolandARicardMOpolonPAdenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapyCancer Res200060133484349210910060
   PubMed Web of Science ®Google Scholar
• BartonKNTysonDStrickerHGENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivoMol Ther20038350851812946325
   PubMed Web of Science ®Google Scholar
• DingliDBergertERBajzerZO’connorMKRussellSJMorrisJCDynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporterBiochem Biophys Res Commun2004325115716615522214
   PubMed Web of Science ®Google Scholar
• GoelACarlsonSKClassicKLRadioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter geneBlood200711072342235017515401
   PubMed Web of Science ®Google Scholar
• ShenWPatnaikMMRuizARussellSJPengKWImmunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemiaBlood2016127111449145826712908
   PubMed Web of Science ®Google Scholar
• HaddadDChenCHCarlinSImaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporterPLoS One201278e4164722912675
   PubMed Web of Science ®Google Scholar
• HaddadDChenNGZhangQInsertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virusJ Transl Med201193621453532
   PubMed Web of Science ®Google Scholar
• GholamiSChenCHLouEVaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancerFASEB J201428267668224186964
   PubMed Web of Science ®Google Scholar
• MansfieldDCKyulaJNRosenfelderNOncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancerGene Ther201623435736826814609
   PubMed Web of Science ®Google Scholar
• HakkarainenTRajeckiMSarparantaMTargeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporterClin Cancer Res200915175396540319706820
   PubMed Web of Science ®Google Scholar
• MerronAPeerlinckIMartin-DuquePSPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter geneGene Ther200714241731173817960161
   PubMed Web of Science ®Google Scholar
• JhawarSRThandoniABommareddyPKOncolytic viruses-natural and genetically engineered cancer immunotherapiesFront Oncol2017720228955655
   PubMed Web of Science ®Google Scholar
• PardollDMThe blockade of immune checkpoints in cancer immunotherapyNat Rev Cancer201212425226422437870
   PubMed Web of Science ®Google Scholar
• PolJBuquéAArandaFTrial Watch-Oncolytic viruses and cancer therapyOncoimmunology201652e111774027057469
   PubMed Web of Science ®Google Scholar
• BartonKNStrickerHBrownSLPhase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostateMol Ther200816101761176918714306
   PubMed Web of Science ®Google Scholar
• MsaouelPDispenzieriAGalanisEClinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overviewCurr Opin Mol Ther2009111435319169959
   PubMed Web of Science ®Google Scholar
• MsaouelPOpyrchalMDispenzieriAClinical trials with oncolytic measles virus: current status and future prospectsCurr Cancer Drug Targets Epub2017222
   Web of Science ®Google Scholar
• DispenzieriATongCLaPlantBPhase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myelomaLeukemia201731122791279828439108
   PubMed Web of Science ®Google Scholar